The anti-inflammatory role of the erythrocyte: Impairment in the elderly

Archives of Gerontology and Geriatrics

Volumn 24, Issue 2, 1997, Pages 157-165

  Gershon, Harriet ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Complement; CR1; Erythrocytes; Immune complexes; Inflammation

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C5;

ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; COMPLEMENT ACTIVATION; DISEASE PREDISPOSITION; ERYTHROCYTE; HUMAN; INFECTION; INFLAMMATION; PRIORITY JOURNAL; REVIEW; SENESCENCE; VASCULAR TISSUE;

EID: 0031015829     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(96)00748-0     Document Type: Review

References (33)

1. Ahearn, J.M. and Fearon, D.T. (1989): Structure and function of the complement receptors CRI (CD35) and CR2 (CD21). Adv. Immunol., 46, 183-219.
2. Aminoff, D. (1988): The role of sialoglycoconjugates in the aging and sequestration of red cells from circulation. Blood Cells, 14, 229-247.
3. Cohen, J.H.M., Lutz, H.U., Pennaforte, J.L., Bouchard, A. and Kazatchkine, M.D. (1992): Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol., 87, 422-428.
4. Cornacoff, J.B., Hebert, L.A., Smead, W.L., Van Aman, M.E., Birmingham, D.J. and Waxman, F.J. (1983): Primate erythrocyte-immune complex clearing mechanism. J. Clin. Invest., 71, 236-247.
5. Corvetta, A., Pomponio, G., Bencivenga, R., Luchetti, M.M., Spycher, M., Spaeth, P.J. and Danieli, G. (1991): Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cytoglobulinemeia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy. J. Rheumatol., 18, 1021-1025.
6. Currie, M.S., Rustagi, P.K., Wojcieszak, R., Ziolkowski, L., Ross, G.D. and Longue, G.L. (1988): Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b. Blood, 71, 786-790.
7. Fishelson, Z. and Marikovsky, Y. (1987): Reduced CR1 expression and activity on aged erythrocytes [abstract]. Complem., 4, 155-155.
8. Galili, U., Flechner, I., Knyszynski, A., Danon, D. and Rachmilewitz, E.A. (1986): The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br. J. Haematol., 62, 317-324.
9. Glass, G.A., Gershon, H. and Gershon, D. (1983): The effect of donor and cell age on several characteristics of rat erythrocytes. Exp. Hematol., 11, 987-995.
10. Glass, G.A., Gershon, D. and Gershon, H. (1985): Some characteristics of the human erythrocyte as a function of donor and cell age. Exp. Hematol., 13, 1122-1126.
11. Jepsen, H.H., Svehag, S.E., Jensenius, J.C. and Sim, R.B. (1986): Release of immune complexes bound to erythrocyte complement receptor (CRI), with particular reference to the role of factor I. Scand. J. Immunol., 24, 205-213.
12. Kalli, K.R., Ahearn, J.M. and Fearon, D.T. (1991): Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J. Immunol., 147, 590-594.
13. Kay, M.M.B. (1984): Localization of senescent cell antigen on band 3. Proc. Natl. Acad. Sci. USA, 81, 5753-5757.
14. Lutz, H.U., Bussolino, F., Flepp, R., Fasler, S., Stammler, P., Kazatchkine, M.D. and Arese, P. (1987): Naturally occurring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human red blood cells. Proc. Natl. Acad. Sci. USA, 84, 7368-7372.
15. Madi, N., Paccaud, J.-P., Steiger, G. and Schifferli, J.A. (1991): Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clin. Exp. Immunol., 84, 9-15.
16. Medof, M.E., Lam, T., Prince, G.M. and Mold, C. (1983): Requirement for human red blood cells in activation of C3b in immune complexes and enhancement of binding to spleen cells. J. Immunol., 130, 1336-1340.
17. Moldenhaur, F., Botto, M. and Walport, M.J. (1988): The rate of loss of CR1 from aging erythrocytes in vivo with structural or numerical polymorphisms. Clin. Exp. Immunol., 72, 74-78.
18. Muta, K., Sakai, K., Nishimura, J. and Nawata, H. (1991): Reduced erythrocyte complement receptor type 1 in autoimmune thrombocytopenia purpura. Br. J. Haematol., 77, 246-247.
19. Nelson, R.A., Jr. (1991): The immune adherence phenomenon, immunologically specific reaction between micro-organisms and erythrocytes leading to enhanced phagocytosis. Science, 118, 733-737.
20. Pascual, M., Danielsson, C., Steiger, G. and Schifferli, J.A. (1994): Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur. J. Immunol., 24, 702-708.
21. Ripoche, J. and Sim, R.B. (1986): Loss of complement receptor type l (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor. Biochemistry, 235, 815-821.
22. Ross, G.D., Young, W.J., Walport, M.J., Winfield, J.B., Parker, C.J., Fuller, C.R., Taylor, R.P., Myones, B.L. and Lachmann, P.J. (1985): Disease associated loss of erythrocyte complement receptors (CRl,C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol., 135, 2005-2014.
23. Ruuska, P.E., Ikaheimo, I., Silvennoinen-Kassinen, S., Kaar, M.L. and Tiilikainen, A. (1992): Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon? Clin. Exp. Immunol., 89, 18-21.
24. Schifferli, J.A., Ng, Y.C., Estreicher, J. and Walport, M.J. (1988): The clearance of tetanus toxoid/antitetanus toxoid immune complexes from the circulation of humans. Complement and erythrocyte complement receptor 1-dependent mechanisms. J. Immunol., 140, 899-904.
25. Shapiro, S., Kohn, D., Miller, B. and Gershon, H. (1993a): Erythrocytes from young but not elderly donors can bind and degrade immune complex and antibody bound C3 in vitro. Clin. Exp. Immunol., 95, 181-190.
26. Shapiro, S., Kohn, D. and Gershon, H.E. (1993b): A role for complement as the major opsonin in the sequestration of erythrocytes from elderly and young donors. Br. J. Haematol., 83, 648-655.
27. Shapiro, S., Pilar, T. and Gershon, H.E. (1993c): Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors. Clin. Exp. Immunol., 91, 301-307.
28. Sheiban, E. and Gershon, H. (1990): The specific blocking of an IgG dependent erythrophagocytosis assay by protein G and ELISA determination of in situ bound IgG on erythrocytes of normal donors. J. Immunol. Methods, 135, 139-146.
29. Sheiban, E. and Gershon, H. (1993): Mechanism of recognition and sequestration of young and old erythrocytes from young and elderly human donors: in vitro studies. J. Lab. Clin. Med., 121, 493-501.
30. Tausk, F.A., McCutchen, J.A., Spechko, P., Schreiber, R.D. and Gigli, I. (1986): Altered erythrocyte C3b receptor expression, immune complexes and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J. Clin. Invest., 78, 977-982.
31. Taylor, R.P., Horgan, C., Buschbacher, R., Brunner, C.M., Hess, C.E., O'Brien, W.M. and Wanebo, H.J. (1983): Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum., 26, 736-743.
32. Walport, M.J., Ross, G.D., Mackworth-Young, C., Watson, J.V., Hogg, N. and Lachmann, P.J. (1985): Family studies of erythrocyte complement receptor type I levels: reduced levels in patients with SLE are acquired not inherited. Clin. Exp. Immunol., 59, 547-554.
33. Yanagida, K., Takemura, S., Fukuda, W., Kasamatsu, Y., Okamoto, M., Onodera, H., Ueda, M., Deguchi, M., Sugino, S. and Kondo, M. (1989): Measurement of regulatory proteins of complement on peripheral blood cells in SLE and RA [abstract]. Complement Inflamm., 6, 419.